Irvine-based Inari Medical Inc. will be acquired by Stryker Corp. for $4.8 billion. The boards of directors of both companies ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Stryker (NYSE: SYK), a global leader in medical technologies, has announced its definitive agreement to acquire Inari Medical ...

The suspect in the shooting death of CEO Brian Thompson has garnered sympathy and financial support as he awaits trial, a sign that public support could sway the jury, legal analysts contend. More ...

At its height, NAIAS in Detroit was truly an international show, where anyone involved in the auto industry was expected to ...

Canaccord Genuity Group reiterated their hold rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research ...

Seed gene-editing startup Inari has completed a $144 million Series G round, bringing its cumulative funding to $720 million.

Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a ...

With more than 60 acquisitions completed in the last decade, Stryker Corp. shows little fear in committing to offers that allow it to obtain the companies and technologies that have driven its ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...

Stryker has entered a definitive agreement to acquire medical device company Inari Medical for approximately $4.9 billion. Inari was founded in 2011 and focuses on mechanical thrombectomy solutions ...